Publicacións nas que colabora con JOSE ANTONIO CASTILLO SANCHEZ (272)

2024

  1. Differential blood-based biomarkers of subcortical and deep brain small vessel disease

    Therapeutic Advances in Neurological Disorders, Vol. 17

  2. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

  3. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

  4. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation, Vol. 54, Núm. 6

2023

  1. Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship

    Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454

  2. Perfusion-weighted software written in Python for DSC-MRI analysis

    Frontiers in Neuroinformatics, Vol. 17

  3. Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population

    Therapeutic Advances in Chronic Disease, Vol. 14

  4. Periodontitis is associated with subclinical cerebral and carotid atherosclerosis in hypertensive patients: A cross-sectional study

    Clinical Oral Investigations, Vol. 27, Núm. 7, pp. 3489-3498

2022

  1. Antihyperthermic Treatment in the Management of Malignant Infarction of the Middle Cerebral Artery

    Journal of Clinical Medicine, Vol. 11, Núm. 10

  2. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  3. Surrogate biomarkers of outcome for wake-up ischemic stroke

    BMC Neurology, Vol. 22, Núm. 1

  4. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction

    Frontiers in Neurology, Vol. 13

2021

  1. Ceramide metabolism and parkinson’s disease—therapeutic targets

    Biomolecules, Vol. 11, Núm. 7

  2. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  3. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81

  4. Obesity-related genetic determinants of stroke

    Brain Communications, Vol. 3, Núm. 2

  5. Random forest-based prediction of stroke outcome

    Scientific Reports, Vol. 11, Núm. 1

  6. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  7. STWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 528-535

  8. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426